Sodium Butyrate Attenuates Renal Fibrosis by Regulating Glycolysis and Histone H4K12 Lactylation in Diabetic Kidney Disease
Diabetes, Obesity and Metabolism · Published 2026-08-02 · DOI 10.1111/dom.71166
Free full text
Authors (11)
Ping He, Mingxiu Wang, Hang Mei, Yue Liu, Min Wang, He Sun, Yali Peng, Xuan Ban, Yue Wang, Xiaofang Tang, Qiuling Fan
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
He, P., Wang, M., Mei, H., et al. (2026). Sodium Butyrate Attenuates Renal Fibrosis by Regulating Glycolysis and Histone H4K12 Lactylation in Diabetic Kidney Disease. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71166
Related articles
- Economic Impact of Multidisciplinary Pre‐operative Diabetes Care Versus Usual Care in Adults Undergoing Elective Non‐cardiac Surgery in Australia: A Trial‐Based Analysis · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Feasibility of Decentralised Response‐Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Metformin Ameliorates Diabetes‐Associated Cognitive Dysfunction via p53/Parkin‐Mediated Mitophagy · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Trends and Prevalence of Undiagnosed Dysglycemia Among Reproductive‐Age Women in the United States · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Beyond Glycaemia: Fear of Hypoglycaemia, Cognition and Functional Mobility After Advanced Hybrid Closed‐Loop Therapy in Older Adults With Type 1 Diabetes: A Prespecified Secondary Analysis of a Randomised, Single‐Centre Study · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Diagnostic Yield of Structured Cushing Syndrome Evaluation in Treatment‐Resistant Non‐Diabetic Obesity: A Retrospective Pilot Study · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Exercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non‐Insulin Treated Type 2 Diabetes: A Randomised Trial · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Real‐World Effectiveness and Safety of Finerenone in People With Type 2 Diabetes and Chronic Kidney Disease: A Spanish Multicentre Retrospective Observational Study ( MEDFINE ‐ RWD ) · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Methodological and Conceptual Concerns Regarding the 24‐h Glycaemia/C‐Peptide Ratio as a Novel Insulin Sensitivity Index · Diabetes, Obesity and Metabolism · 2026 · Same journal
- Efficacy and Safety of Once‐Weekly Semaglutide 2.0 mg as an Add‐On to Dose‐Reduced Insulin Glargine versus Dose‐Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight ( SUSTAIN OPTIMIZE ) · Diabetes, Obesity and Metabolism · 2026 · Same journal